For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
FROM THE COMMENT STREAM: What they’re saying on nzdoctor.co.nz
Wednesday 31 July 2024, 12:00 AM

Capitation fees, AI futures and workforce issues have got people talking on nzdoctor.co.nz [Nina Ray on iStock]
The 4 per cent capitation increase, AI’s role in saving general practice, and workforce woes are just some of the issues getting readers talking
Funding tweaks, Te Whatu Ora did not budge on the rejected 4 per cent capitation increase, but made some minor changes to the PHO Services Agreement, including allowi
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.